FAQs about Health » Cardiovascular

News about Health » Cardiovascular

Anifrolumab vs Belimumab in Lowering SLE Cardiovascular Risk - Medscape [Visit Site | Read More]

ESC 2026 Interview: Marco Roffi - EMJ [Visit Site | Read More]

Coronary Microvascular Dysfunction and Major Adverse Cardiovascular Events in Patients With Ischemia and Non-obstructive Coronary Arteries: A Systematic Review - Cureus [Visit Site | Read More]

Semaglutide’s heart benefits may partly involve reduced inflammation - News-Medical [Visit Site | Read More]

1 in 5 people over 40 face cardiovascular risk in 2 coastal upazilas: Study - The Daily Star [Visit Site | Read More]

Study found artery damage in adults in their 20s, highlighting need for early cardiovascular risk assessment - www.heart.org [Visit Site | Read More]